BUD library

Conveniently packaged in a searchable format with quick access to associated formulas and validated stability-indicating studies conducted by third party institutions - our beyond-use-date (BUD) library provides reassurance on the stability of commonly prepared compounded medications including pediatric oral liquids, hormone creams, analgesic creams, hair care foams, and more.

Search our BUD studies

API(s) & Strength
Route of DeliveryDosage FormBase
Extended BUD Result
Formula Number
Acetazolamide 25 mg per mL Oral Liquid
OralLiquidMEDISCA ORAL MIX SF
90 days at 5°C and 25°C
Acetazolamide 25 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX SF
90 days at 5°C and 25°C
Acetazolamide 25 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX
90 days at 5°C and 25°C
Allopurinol 20 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX90 days at 5°C and 25°C
Allopurinol 20 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX SF90 days at 5°C and 25°C
Benzocaine 20%, Lidocaine 6%, Tetracaine 4% Topical Cream
TopicalCreamMEDISCA VERSAPRO CREAM BASE
180 days at RT
Clonidine Hydrochloride 0.01 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX
90 days at 4°C and 25°C
Clonidine Hydrochloride 0.01 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX SF
90 days at 4°C and 25°C
Clozapine 25 mg to 50 mg per mL Oral Liquid *
OralLiquidMETHYLCELLULOSE GEL 1% & MEDISCA ORAL SYRUP
120 days at 4°C and 25°C
Cyclobenzaprine Hydrochloride 5%, Diclofenac Sodium 10%, Lidocaine 5% Topical Cream
TopicalCreamMEDISCA VERSAPRO CREAM BASE
180 days at RT
Dexamethasone 1 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX
90 days at 4°C and 25°C
Dexamethasone 1 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX SF
90 days at 4°C and 25°C
Dexamethasone Phosphate 1 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX
90 days at 4°C and 25°C
Dexamethasone Phosphate 1 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX SF
90 days at 4°C and 25°C
DHEA 0.2%-4%, Estradiol 0.01%-0.2%, Estriol 0.04%-0.8%, Progesterone 1%-20%, Testosterone 0.025%-0.5% Topical Creamcontrolled substance
TopicalCreamMEDISCA HRT CREAM BASE
180 days at RT
DHEA 0.2%-4%, Estradiol 0.01%-0.2%, Estriol 0.04%-0.8%, Progesterone 1%-20%, Testosterone 0.025%-0.5% Topical Creamcontrolled substance
TopicalCreamMEDISCA VERSAPRO CREAM BASE
180 days at RT
Diazoxide 10 mg per mL Oral Liquid
OralLiquidMEDISCA ORAL MIX SF
90 days at 4°C and 25°C
Diazoxide 10 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX
90 days at 4°C and 25°C
Diazoxide 10 mg per mL Oral Liquid *
OralLiquidMEDISCA ORAL MIX SF
90 days at 4°C and 25°C
Diclofenac Sodium 1% to 15% Topical Cream
TopicalCreamMEDISCA VERSAPRO CREAM BASE
180 days at RT

Rows per page

1 - 20

Speak to an expert today

From regulatory compliance to subject matter expertise, our team of pharmacists provides tailored solutions to elevate your compounding practice.
controlled substance= Controlled substance
* Preparation compounded using commercial drug product (ex. tablet, capsule, sterile powder for injection)
Disclaimer: Preparation compounded using commercial drug product (ex. tablet, capsule, sterile powder for injection) This data is provided for informational purposes only, representing the results of a study of the product stability with various active pharmaceutical ingredients. For further information on packaging, please refer to the actual formula. This document does not serve, and may not be construed, as a representation or guarantee of product performance. In all cases, the practitioner is advised to consult recognized pharmaceutical compendia and other recognized sources for product formulation and other product characteristics, including stability. MEDISCA and its affiliates make no warranties or representations with regards to the functioning or appropriateness of this product in any compounded formulation, the use of which is solely at the discretion and liability of the practitioner. It is the responsibility of the pharmacist or other appropriately state licensed professional to verify the accuracy and validity of the information contained herein, with regards to scheduling, federal and state/provincial laws allowing the use of the formulas, products and final compounds in the country of use.